arginine vasopressin has been researched along with pyridoxal phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Custer, EE; Knott, TK; Lemos, JR; Marrero, HG | 1 |
| Cuadra, AE; Custer, EE; Knott, TK; Lemos, JR; Ortiz-Miranda, S | 1 |
2 other study(ies) available for arginine vasopressin and pyridoxal phosphate
| Article | Year |
|---|---|
Endogenous ATP potentiates only vasopressin secretion from neurohypophysial terminals.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Antineoplastic Agents; Arginine Vasopressin; Male; Nerve Endings; Oxytocin; Patch-Clamp Techniques; Pituitary Gland, Posterior; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Suramin; Vasopressins | 2008 |
P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arginine Vasopressin; Electric Stimulation; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Oxytocin; Pituitary Gland, Posterior; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Suramin | 2012 |